Article

Frailty and Age Impact Immune Responses to Moderna COVID-19 mRNA Vaccine

2022-08-01

Abstract excerpt

BACKGROUND Immune responses to COVID-19 mRNA vaccines have not been well characterized in frail older adults. We postulated that frailty is associated with impaired antibody and cellular mRNA vaccine responses. METHODS We followed older adults in a retirement facility with longitudinal clinical and serological samples from the first Moderna mRNA-1273 vaccine dose starting in February 2021 through their 3rd (booste...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0f2cc69b-fb6f-58da-9e02-1ad3f6968991
DOI: 10.21203/rs.3.rs-1883093/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Frailty and Age Impact Immune Responses to Moderna COVID-19 mRNA VaccineDOI 10.21203/rs.3.rs-1883093/v1Read

Kinetics of COVID-19 mRNA primary and booster vaccine-associated neutralizing activity against SARS-CoV-2 variants of concern in long-term care facility residents: A prospective longitudinal studySemantic proximity Read

Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care FacilitiesSemantic proximity Read

Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adultsSemantic proximity Read

Competent immune responses to SARS-CoV-2 variants in older adults following mRNA vaccinationSemantic proximity Read

Mitigation of imprinted antibody responses against COVID-19 in highly vaccinated older adultsSemantic proximity Read

Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infectionSemantic proximity Read

Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderlySemantic proximity Read

Adjusted booster schedules disperse age-dependent differences in antibody titers benefitting risk populationsSemantic proximity Read

Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concernSemantic proximity Read

Impact of peripheral mitochondrial DNA level on immune response after COVID-19 vaccinationSemantic proximity Read

mRNA-COVID19 vaccination can be considered safe and tolerable for frail patientsSemantic proximity Read

Declined Antibody Responses to COVID-19 mRNA Vaccine within First Three MonthsSemantic proximity Read